
Targeting refractory prostate cancer: a novel radiopharmaceutical hits the bull’s-eye
Tadashi Watabe ≪Nuclear Medicine and Tracer Kinetics≫
European Journal of Nuclear Medicine and Molecular Imaging

Tadashi Watabe ≪Nuclear Medicine and Tracer Kinetics≫
European Journal of Nuclear Medicine and Molecular Imaging

Reiichi Sugihara, Yuki Kato ≪RNA Biology and Neuroscience≫
Nature Communications

Daisuke Ino, Hiroshi Hibino ≪Division of Glocal Pharmacology≫
Nature Methods

Keisuke Tabata, Maho Hamasaki, Tamotsu Yoshimori ≪Genetics≫
Cell Reports

Yuki Togami, Hisatake Matsumoto, Hiroshi Ogura ≪Traumatology and Acute Critical Medicine≫
Molecular Therapy-Nucleic Acids

Jotaro Tachino, Hisatake Matsumoto ≪Traumatology and Acute Critical Medicine≫
Critical Care

Yoshiaki Yasumizu, Tatsusada Okuno, Hideki Mochizuki ≪Neurology≫, Naganari Ohkura≪Frontier Research in Tumor Immunology≫, Yasushi Shintani ≪General Thoracic Surgery≫, Eiichi Morii ≪Histopathology≫
Nature Communications

Yuki Makino; Hayato Hikita, Tetsuo Takehara ≪Gastroenterology and Hepatology≫
Cancer Research

Yoshiki Omatsu, Takashi Nagasawa ≪Stem Cell and Applied Medicine≫
Nature Communications

Rika Yamashita, Goichi Beck, Hideki Mochizuki ≪Neurology≫
Movement Disorders